1. Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease Hughes, Tasha; Iodice, Gail M.; Basu, Sanjib; Bines, Steven; Kaufman, Howard 2013 Presentations (Communicative Events) Cancer--ImmunotherapyMelanoma--TreatmentRenal cell carcinomaInterleukin-2ImmunotherapyOncologyMedicineImmunology
2. Convection-Enhanced Delivery for Targeted Delivery of Antiglioma Agents: The Translational Experience Yun, Jonathan; Rothrock, Robert J.; Canoll, Peter D.; Bruce, Jeffrey N. 2013 Articles NeurosciencesOncologyMedicineGlioblastoma multiforme
3. The role of surgery following incomplete response to high-dose IL-2 (HD IL-2) Hughes, Tasha; Iodice, Gail M.; Basu, Sanjib; Bines, Steven; Kaufman, Howard 2013 Presentations (Communicative Events) Excision (Surgery)Metastasis--SurgeryMetastasisMetastasis--TreatmentCancer--SurgeryCancer--ImmunotherapyInterleukin-2OncologyMedicineSurgeryImmunology
4. Tumor-associated T cell receptor repertoires in low- and high-grade gliomas Sims, Jennifer S.; Grinshpun, Boris; Amendolara, Benjamin; Shen, Yufeng; Canoll, Peter D.; Sims, Peter A.; Bruce, Jeffrey N. 2013 Presentations (Communicative Events) AstrocytomasGliomasT cells--ReceptorsExcision (Surgery)Cancer--SurgeryGlioblastoma multiformeOncologySurgeryMedicine